[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Select Eye Care\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":45},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":27,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":34,"lastUpdatePostDateStruct":35,"startDateStruct":38,"completionDateStruct":40,"leadSponsor":42,"locationsCount":5},"100604294","direct-selective-laser-trabeculoplasty-dslt-for-reducing-eye-pressure-in-non-caucasian-patients-with-open-angle-glaucoma-100604294",false,"NCT07147647","Direct Selective Laser Trabeculoplasty (DSLT) for Reducing Eye Pressure in Non-Caucasian Patients With Open Angle Glaucoma","Efficacy of Direct Selective Laser Trabeculoplasty (DSLT) for Reducing Intraocular Pressure in Non-Caucasian Open Angle Glaucoma Patients","Inclusion Criteria:\n\n* Adult patients of Black African descent scheduled to undergo DSLT treatment in one or both eyes.\n* Diagnosis of mild to moderate primary open angle glaucoma (POAG).\n* Mild to moderate POAG will be defined as Stage 2 or better of the Hodapp-Anderson-Parrish glaucoma staging system.\n* Treatment naive or washed out IOP at time 0 ranging from ≥ 21 through 32 mm Hg.\n\nExclusion Criteria:\n\n* Screened patients who were on IOP-lowering medications who did not successfully complete medication washout at the time of the procedure (time 0).\n* Previous glaucoma surgeries\u002Finterventions:\n* Patients who have undergone prior glaucoma-related procedures (e.g., trabeculectomy, laser trabeculoplasty, MIGS, or tube shunt).\n* Secondary glaucoma:\n* Patients with secondary forms of glaucoma, such as angle-closure glaucoma, neovascular glaucoma, or glaucoma resulting from trauma or other systemic diseases.\n* Other significant ocular conditions including advanced cataracts, retinal diseases (e.g., age-related macular degeneration), or any condition that might complicate the assessment of intraocular pressure (IOP) or visual function as deemed by the investigator.\n* Subjects who are pregnant, breast-feeding, or intend to become pregnant during the study period as determined by verbal inquiry.","ALL","18 Years",{"count":19,"type":20},60,"ESTIMATED","INTERVENTIONAL",[23],"NA","The goal of this clinical trial is to to evaluate how well Direct Selective Laser Trabeculoplasty (DSLT) lowers eye pressure in eyes of adult, non-Caucasian participants with primary open angle glaucoma. The main question it aims to answer is:\n\nWhat is the washed out eye pressure (eye pressure when not on any glaucoma medications) of participants 6 months after the Direct Selective Laser Trabeculoplasty (DSLT) procedure compared to the washed out eye pressure of participants prior to the DSLT procedure.\n\nParticipants will:\n\nUndergo the DSLT procedure in one or both eyes and visit the clinic 1 month, 3 months, and 6 months after the procedure to have their vision and eye pressure measured.",[26],"Primary Open Angle Glaucoma (POAG)",[28,29,30,31,32],"Direct Selective Laser Trabeculoplasty","DSLT","Primary Open Angle Glaucoma","POAG","Glaucoma","RECRUITING","2025-08-22",{"date":36,"type":37},"2025-08-29","ACTUAL",{"date":39,"type":37},"2025-07-16",{"date":41,"type":20},"2026-10",{"name":43,"class":44},"Select Eye Care","INDUSTRY",""]